HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
F Cusano Selected Research
F Cusano Research Topics
Disease
2
Atopic Dermatitis (Atopic Eczema)
01/2022 - 08/2021
2
Psoriasis (Pustulosis Palmaris et Plantaris)
03/2021 - 01/2019
2
Disease Progression
06/2014 - 01/2011
2
Vitiligo
01/2011 - 09/2007
2
Autoimmune Diseases (Autoimmune Disease)
01/2011 - 09/2007
1
Pruritus (Itching)
08/2021
1
Edema (Dropsy)
06/2014
1
Brain Edema (Cerebral Edema)
06/2014
1
Glioma (Gliomas)
06/2014
1
Neoplasms (Cancer)
02/2009
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2009
1
Thyroid Diseases (Thyroid Disease)
09/2007
Drug/Important Bio-Agent (IBA)
2
dupilumab
IBA
01/2022 - 08/2021
2
Autoantibodies
IBA
01/2011 - 09/2007
1
Monoclonal Antibodies
IBA
08/2021
1
Interleukin-4 (Interleukin 4)
IBA
08/2021
1
dimemorfan (AT 17)
IBA
03/2021
1
brodalumab
IBA
03/2021
1
Prostaglandins A
IBA
03/2021
1
HLA-C*06 antigen
IBA
01/2019
1
secukinumab
IBA
01/2019
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
06/2014
1
Dexamethasone (Maxidex)
FDA Link
Generic
06/2014
1
Nucleotides
IBA
06/2014
1
Biomarkers (Surrogate Marker)
IBA
06/2014
1
ErbB Receptors (EGF Receptor)
IBA
02/2009
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
02/2009
Therapy/Procedure
2
Therapeutics
03/2021 - 06/2014